Janux Therapeutics (JANX) Current Leases (2021 - 2026)
Janux Therapeutics (JANX) posted quarterly Current Leases of $2.5 million for Q1 2026, up 36.5% year-over-year from $1.8 million in Q1 2025, and up 3.3% quarter-over-quarter from $2.4 million in Q4 2025.
Janux Therapeutics (JANX) Current Leases (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Current Leases for 6 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 36.5% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 36.5% YoY), while the FY2025 annual figure was $2.4 million, up 36.82% from the prior year.
- Current Leases climbed to $2.5 million in Q1 2026 per JANX's latest filing, from $2.4 million in the prior quarter.
- Across five years, Current Leases topped out at $2.5 million in Q1 2026 and bottomed at $88000.0 in Q2 2022.
- Historically, Current Leases has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2023 — Current Leases soared 1500.0% — and 2025, when it increased 14.91%.
- Janux Therapeutics' Current Leases stood at $763000.0 in 2022, then surged by 98.82% to $1.5 million in 2023, then rose by 15.29% to $1.7 million in 2024, then surged by 36.82% to $2.4 million in 2025, then rose by 3.3% to $2.5 million in 2026.
- Business Quant data shows JANX's Current Leases at $2.5 million in Q1 2026, $2.4 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 763,000.00 |
| Jun 30, 2022 | 88,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Dec 31, 2021 | 194,000.00 |
| Sep 30, 2021 | 212,000.00 |